Flask Real Time Analytics Help Flaskdata Customer Detect Early Stage Lung Cancer With Blood Test

Flaskdata.io, a SaaS company based out in Modlin, Israel, is proud to announce that the Flaskdata.io data collection platform is being used by a customer in the detection of early stage lung cancer with a simple blood test. Flaskdata.io specializes in helping life sciences companies complete their Phase 2 and Phase 3 clinical trials 3-6 months faster.

Danny Lieberman, CEO of Flaskdata.io, says, “Nucleix uses the Flask API to seamlessly pull data from the Flaskdata.io platform into their machine-earning system in order to train the early cancer detection system with high quality validated clinical data. It is our privilege to work with Nucleix on their early detection program for early stage lung and liver cancers.”

Nucleix Ltd. develops, manufactures and markets innovative, non-invasive molecular cancer diagnostic tests. The company’s highly sensitive and specific tests are based on identification of subtle changes in methylation patterns. Their first product, Bladder EpiCheck, is a urine test for monitoring bladder cancer. The company has been working with Flaskdata.io on their newest test to detect early stage lung cancer and recently succeeded in their efforts. However, Nucleix is far from the first successful company to use and take advantage of Flaskdata’s services. The customer case studies page on the Flaskdata website contains details about other such success stories.

A representative for Flaskdata.io says, “We have always worked with the aim of furthering modern life sciences and assisting companies in developing new tests that will change the field of medicine. The success of Nucleix’s new testing method will allow for the early detection and treatment of thousands of people around the world who are suffering from lung cancer. We are proud to have been a part of that effort.”

Flaskdata.io provides a SaaS platform for clinical trial management that helps device and drug sponsors get interpretable data in an immediate picture. Early adopter biomed and biotech companies in Israel and the US are using the technology to automate quality assurance of the data and to enable physicians, study nurses and site coordinators to focus on caring for patients.

Flaskdata.io’s AI-driven detection and playbook response reinforces high protocol and procedural adherence and delivers high quality risk signals starting from the first patient. The Flaskdata.io platform is built in a component architecture that exposes functionality via the Flask API. This enables sponsors, digital health platforms, medical devices and digital therapeutics to easily pick and choose what functionality they want to implement on the platform.

Flaskdata offers a number of products. One such product is Flask Forms, a patient engagement application that runs on mobile devices and desktops. It allows medical research companies to create an application in minutes using a friendly drag and drop UI. Flask API is a powerful and secure mobile/device API service that enables companies to collect data from mobile medical devices as well as medical devices connected at home or worn by the subject. However, Flask API does not stop there. Flask API exposes all of the Flask system functionality to developers, from adding subjects, creating forms and user management all the way to data extracts. The company also provides products that allow for continuous data feeds (Flask Data Digital Digest) and patience compliance automation (Flask Data Detect & Respond).

Flaskdata.io’s representative says, “While the Israeli life science industry has had many groundbreaking innovations, we lack a domestic market for the products. This effectively means that every life science company in Israel must innovate locally and work globally in their clinical research, manufacturing, sales and marketing. This creates an ideal proving ground for Flaskdata.io to develop battle-proven products for the global clinical trials monitoring industry. We collaborate with our partners to develop business—innovating locally and working globally. If you want to grow your business and work with a tech company that thinks differently about managing clinical trials, then we want to talk to you. If you are interested in working with us, get in contact for more information.”

Those who want to learn more about Flaskdata and the various services they provide can find more information on the company’s website. Additionally, the company encourages interested parties to get in touch with them directly via email or phone. They can also be reached through the contact form on their website. Furthermore, Flaskdata maintains a presence on LinkedIn where they frequently post updates, share media and communicate with their clients.